The 15-Minute Visit Is Breaking Medicine. Here Is What Replaces It.
The standard primary care slot was built for billing, not for patients. The practices redesigning it are finding that time is the most undervalued clinical tool they own.
Section
Leadership
Management thinking for the physicians who lead departments, groups, and health systems.
More in Leadership
What a Physician Compensation Committee Owes the Group It Serves
Compensation plans shape behavior more than any mission statement. Committees that earn trust focus on transparency, simple rules, and a predictable process for change, not clever formulas.
Why a Board Seat Asks More of Physicians Than They Expect
Physicians are increasingly invited onto hospital, health system, and nonprofit boards. The value they bring depends on learning a new role, one built on governance rather than management.
Making the Physician and Administrator Dyad Work Before It Breaks
Dyad leadership pairs a physician with an operational leader to run a service line or department. It works when roles are explicit and both partners protect a shared agenda.
Who Runs the Practice When You Step Back
Physician groups plan carefully for new equipment and new hires, then leave leadership succession to chance. A deliberate plan protects the practice, its patients, and the people who built it.
Why Good Clinical Changes Die on the Floor, and How to Save Them
Most new protocols and workflows are sound on paper and abandoned in practice. Successful change depends less on the idea than on how leaders introduce, test, and support it.
Rebuilding the M and M Conference Around Systems Instead of Blame
Morbidity and mortality conferences can teach an entire department or quietly humiliate one physician. How leaders structure the hour decides which one happens.
Across The Script Pad
Home →
What the AMA's House of Delegates Decided in Orlando, From AI Licensure to Downcoded Claims
By our count the AMA adopted 15 policies at its Nov. 6-9 meeting, including a bar on licensing AI as a physician and EHR alerts for downcoded claims.
Pimicotinib Gives Tenosynovial Giant Cell Tumor a Third Oral Drug, and the First Taken Once a Day
The FDA approved pimicotinib on Nov. 10 after a 56 percent week-25 response rate, the third CSF-1R inhibitor for TGCT and the only one dosed daily.
How Does Oral Orforglipron Compare With Tirzepatide for Obstructive Sleep Apnea?
Orforglipron cut sleep apnea events 12 to 13 an hour more than placebo in ATTAIN-OSA, against 20 to 24 on tirzepatide's label, largely tracking weight loss.
Seventeen Physician Specialties Are Now Severe Shortages at One in Five VA Facilities or More
The VA inspector general's 2026 survey found severe physician shortages at 135 of 139 facilities, with radiology, urology and anesthesiology rising most.